Thermo Fisher Archives - Medical Design Sourcing

29 cutting-edge medtech innovations recognized with Edison Awards

More than two dozen medical technology developers are winners of the 2023 Edison Awards.

The 29 medtech winners include products from Boston Scientific, Shockwave Medical, Thermo Fisher, DermaSensor and Endiatx. They span four categories: engineering and robotics; health, medical and biotech; manufacturing and logistics; and personal technology and gadgets. Subcategories include smart wearables, noninvasive medtech, advanced drug delivery, AI-assisted medicine, operating room integration and more.

The winners are all finalists for gold, silver and bronze awards. Those awards will be revealed at the Edison Awards Gala on April 20, 2023, in Fort Myers, Florida.

Endiatx co-founder and CEO Torrey Smith with PillBot [Photo by Hardy Wilson for MDO]

Special honors went to Endiatx, which stands by itself as a “game changer” among the approximately 150 Edison Awards winners. Medical Design &…

Thermo Fisher Scientific launches cell therapy manufacturing tech

[Image from Thermo Fisher]

Thermo Fisher Scientific (NYSE:TMO) announced today that it unveiled the Gibco CTS DynaCellect magnetic separation system.

Waltham, Massachusetts-based Thermo Fisher designed DynaCellect to help cell therapy developers easily move from process and clinical development to commercial manufacturing.

The next-generation instrument features cell isolation, activation and depletion along with Dynabeads magnetic beads removal. Thermo Fisher said in a news release that it helps to provide a scalable, flexible, automated and closed system for cell therapy manufacturing.

DynaCellect helps to isolate the right cells and minimize failures in manufacturing. The company expects it to support the commercialization of high-performing therapies and the next class of cell therapy breakthroughs. The system features high throughput capacity and process flexibility.

Thermo Fisher lever…

Key Tech names next CEO as co-founder plans to retire

Key Tech co-founder and CEO Jenny Regan [Photo courtesy of Key Tech]

Key Tech co-founder Jenny Regan plans to retire as CEO of the product development firm at the end of August, making way for VP of Strategy Alex Flamm to take her place.

Regan has been CEO since she and her co-founders launched the Baltimore firm in 1998. The company said it now has 75 interdisciplinary medical product designers and hundreds of clients in the medical technology industry, including Becton Dickinson, GE, Thermo Fisher, HemoSonics, GenMark and Abiomed.

Regan, who led Key Tech’s transition to a fully employee-owned company in 2019, will join the Key Tech Advisory Board.

“I’m incredibly proud of what we’ve built and how much good we’ve been able to do,” Regan said in an announcement posted to the company’s website last week. “I’m confident in our new leadership and will always be inspired by the talen…

Thermo Fisher opens plant to make COVID-19 testing supplies

(Image courtesy of Thermo Fisher)

Thermo Fisher Scientific (NYSE:TMO) announced today that it has opened its $40 million manufacturing facility in Lenexa, Kan.

The facility is dedicated to viral transport media (VTM) but will continue to expand to meet expected demand for COVID-19 testing, according to a news release.

In May, Thermo Fisher received a U.S. government contract to provide a significant quantity of highly specialized VTM for COVID-19 sample collection. The company said it ramped up production in Lenexa from 50,000 units per week to more than 8 million per week since the facility began production in early July.

Thermo Fisher said in the release that the new facility has created more than 300 new full-time jobs as it added 120,000 ft2 of manufacturing capacity.

Get the full story on our sister site, MassDevice.

DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?

DeviceTalks Weekly, powered by MassDevice

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week’s Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they’re making in developing a device to treat diabetes.

In a second interview, bioelectronic device company Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success in treating essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW communit…